Name: Kiniksa Pharmaceuticals International, plc (KNSA) Balance Sheet
Creator: FinSpry

Kiniksa Pharmaceuticals International Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Kiniksa Pharmaceuticals International, plc (KNSA) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
Current Assets
Cash and Cash Equivalents	183.58	107.95	190.61	182.20	323.48	233.38	307.30
Short-Term Investments	60.05	98.42	67.89	59.73	209.44	0.00	0.00
Cash & Short-Term Investments	243.63	206.37	190.61	182.20	323.48	233.38	307.30
Accounts Receivable	41.72	21.27	20.32	3.99	0.00	0.00	0.00
Inventory	26.36	31.12	21.60	3.68	0.00	0.00	0.00
Other Current Assets	20.08	17.54	1.79	0.55	0.84	0.53	0.00
Total Current Assets	331.80	276.30	243.06	196.45	333.25	241.63	313.75
Non-Current Assets
Property, Plant & Equipment (Net)	11.04	12.67	7.04	8.38	10.62	8.33	6.36
Intangible Assets	16.25	17.25	18.25	19.25	0.00	0.00	0.00
Other Non-Current Assets	10.32	0.83	5.82	8.72	5.59	0.21	0.21
Total Non-Current Assets	248.75	250.03	216.61	36.35	16.22	12.91	8.22
Total Assets	580.55	526.32	459.67	232.80	349.46	254.53	321.97
Current Liabilities
Accounts Payable	2.04	8.25	38.01	39.90	29.70	26.11	36.66
Short-Term Debt	1.99	0.00	0.00	0.00	0.00	0.00	0.00
Accrued Liabilities	80.51	44.67	30.11	29.12	29.20	0.00	0.00
Deferred Revenue	0.00	0.31	0.00	0.00	0.00	0.00	0.00
Other Current Liabilities	16.08	8.19	5.75	1.54	0.04	0.03	0.22
Total Current Liabilities	100.62	63.67	47.07	44.82	31.85	27.83	42.55
Non-Current Liabilities
Long-Term Debt	7.86	10.01	2.62	2.67	4.88	0.96	0.00
Other Non-Current Liabilities	1.82	1.86	1.84	0.27	0.81	0.33	0.14
Total Non-Current Liabilities	41.50	23.82	16.46	2.94	5.68	1.28	0.14
Total Liabilities	142.12	87.48	63.52	47.76	37.53	29.11	42.70
Stockholders' Equity
Common Stock	0.02	0.02	0.02	0.02	0.02	0.00	0.00
Retained Earnings	-521.14	-477.95	-491.99	-675.46	-517.51	-356.09	-194.23
Accumulated Other Comprehensive Income	-0.16	0.01	0.04	-0.07	-0.03	0.03	0.00
Additional Paid-in Capital	959.72	916.76	888.12	860.48	829.42	581.47	473.48
Shares Outstanding	72.52	70.46	69.70	69.06	0.00	0.00	0.00
Total Stockholders' Equity	438.44	438.84	396.14	185.03	311.93	225.41	279.27
Total Liabilities & Equity	580.55	526.32	459.67	232.80	349.46	254.53	321.97